Unik-Sin Tablet (Clonixin Lysinate)

Adult dose

○ Adults : Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication should be used with caution in individuals who regularly consume more than three alcoholic beverages daily, as it may cause gastrointestinal bleeding; consultation with a doctor or pharmacist is essential. This medication can affect the cardiovascular system and may increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke; patients with a history of cardiovascular diseases or risk factors should be particularly careful. It may cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations, so elderly patients or those with a history of gastrointestinal diseases should be cautious when taking this medication. Patients with peptic ulcers, those who have developed gastrointestinal issues from medications, those allergic to this medication or its components, individuals with specific asthma or allergy histories, women who are pregnant or may become pregnant, and patients with severe liver, kidney, or heart diseases should not take this medication. The risk of adverse effects may increase when taken in combination with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, warfarin, etc., so it is advised not to take them together without consulting a physician. Individuals with a history of peptic ulcers, elderly patients, those with hypertension, heart failure, liver or kidney disease should consult healthcare professionals before taking this medication. While taking this medication, if symptoms such as gastrointestinal bleeding, skin rash, respiratory difficulties, abnormal liver function, or hematological abnormalities occur, immediately discontinue use and consult a physician. This medication should be administered at the minimum effective dose and for the shortest duration possible, and regular blood tests along with liver and kidney function tests are needed for long-term use. When this medication is given to breastfeeding women, it may cause adverse reactions in infants, so either breastfeeding should be stopped or the medication should be discontinued. Keep out of reach of children, and do not transfer to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcer, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, euphoric sensations, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, severe bronchospasm

Drug interactions

Do not take this medication in combination with non-steroidal anti-inflammatory drugs, ACE inhibitors or angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, coumarin anticoagulants (such as warfarin), cyclosporine, and tacrolimus, antiplatelet agents, or selective serotonin reuptake inhibitors (SSRIs), corticosteroids. Patients receiving treatment for peptic ulcers with misoprostol, etc., should consult a physician.

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is crucial to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the medication's efficacy.

Appearance

Red-brown round film-coated tablet

Package unit

10 tablets/PTP